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INTRODUCTION 
The major responsibility of the anaesthesiologist is to provide 
adequate ventilation to the patient. The most vital element in providing 
functional respiration is the airway.  
  Management of the airway has come a long way since the 
development of endotracheal intubation by Macewen in 1880 to present 
day use of modern and sophisticated airway devices.1 
Using an endotracheal tube to secure a patient's airway is still the 
gold standard. Most routine orotracheal or nasotracheal intubations are 
performed with the help of a laryngoscope that has a curved or straight 
blade.  
Difficulties encountered during intubation can be due to a number 
of factors and may be difficult to predict. It is important to have a 
strategy prepared and to be familiar with the equipment. This will help 
to avoid potential morbidity or mortality from the sequelae of hypoxia 
and/or cardiovascular catastrophe that may result from a failed 
intubation. 
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The anaesthesiologist must be familiar with the major decision 
making components of the difficult airway algorithm. Over the years 
many attempts have been made to address various factors responsible 
for difficult intubations and this has resulted in a number of different 
techniques. It is best to use affordable, safe and useful adjuncts that are 
best suited to our particular anaesthetic set up.    
Insertion of a supraglottic device in these situations is a 
recognised alternative and may be a life-saving procedure. Some 
supraglottic devices allow for subsequent tracheal intubation using a 
blind or a fibreoptic technique. Tracheal intubation through a classical 
laryngeal mask airway had been extensively studied and is more time 
consuming.3 – 5 
One device commonly used as a conduit for intubation is the 
intubating laryngeal mask airway (ILMA).2 The ILMA has been the 
“gold standard” among the supraglottic airway devices since 1997. It 
has showed a high success rate for blind or fibreoptic-guided tracheal 
intubation in patients with both expected and unexpected difficult 
airways. 6– 10 
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 I-GEL supraglottic airway (Intersurgical Ltd., Wokingham, UK) 
is a relatively new device for airway management. It is made from 
Styrene Ethylene Butadiene Styrene and is anatomically preformed to 
mirror the peri-laryngeal structures. It can be described as an uncuffed 
peri-laryngeal sealer according to Miller’s classification .11 
We chose the I-GEL airway in comparison with the ILMA mainly 
because both devices allow direct tracheal intubation. I-GEL airway has 
some potential benefits over the ILMA: it is disposable, cheap and has 
an additional channel for drainage of gastric contents. Moreover, 
insertion of the I-GEL is usually easy and quick .12 
 Furthermore, its wide bore facilitates direct passage of a standard 
size tracheal tube. It can be a useful adjunct to tracheal intubation in 
patients with difficult airway as documented in several case reports.13, 14 
Data for the I-GEL airway as a conduit for blind endotracheal intubation 
is not available as only case reports have been published. 
Hence a prospective randomized single blind study was designed 
to compare the new supraglottic airway device, I-GEL, to ILMA as a 
conduit for blind endotracheal intubation in patients undergoing elective 
surgery under general anaesthesia. 
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AIM OF THE STUDY 
The aim of the study is to compare two supraglottic airway 
devices: I-GEL and Intubating LMA as a conduit for blind endotracheal 
intubation in patients undergoing elective surgery under general 
anaesthesia. We compare the two devices on the following metrics: 
1) First attempt success rate for blind endotracheal intubation 
through the supraglottic airway device. 
2) Total time required for the successful blind endotracheal 
intubation through the supraglottic airway device. 
3) Ease of placement of supraglottic airway device 
a) Number of attempts required for the placement of the 
supraglottic airway device 
b) Time required for the placement of the supraglottic airway 
device. 
 
 
 5
I-GEL 
 The I-GEL airway is a novel and innovative supraglottic airway 
management device, made of a medical grade thermoplastic elastomer, 
Styrene Ethylene Butadiene Styrene, which is soft, gel-like and 
transparent. The I-GEL is a truly anatomical device designed to create a 
non-inflatable anatomical seal of the pharyngeal, laryngeal and peri-
laryngeal structures while avoiding the compression trauma that can 
occur with inflatable supraglottic airway devices. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: The I-GEL Device 
 I-GEL has several potential advantages including (a) easier 
insertion, (b) minimal risk of tissue compression, (c) stability after 
insertion (i.e. no position change with cuff inflation), and (d) latex free, 
sterile, single patient use device.  
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The buccal cavity stabiliser provides good vertical stability and 
axial strength upon insertion. It houses a standard airway channel and a 
separate gastric channel. It is not necessary to insert fingers into the 
mouth of the patient for achieving full insertion.15 
An integrated gastric channel can provide an early indication of 
regurgitation, facilitates venting of gas from the stomach and allows for 
the passing of a naso-gastric tube to empty the stomach contents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Interior of the I-GEL Device 
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COMPONENTS OF I-GEL 
Soft non-inflatable cuff 
 The novel soft non-inflatable cuff fits snugly onto the 
perilaryngeal framework, mirroring the shape of the epiglottis, 
aryepiglottic folds, piriform fossae, peri-thyroid, peri-cricoid, posterior 
cartilages and spaces. Each receives an impression fit, thus supporting 
the seal by enveloping the laryngeal inlet. The tip lies in the proximal 
opening of the oesophagus, isolating the oesophageal opening from the 
laryngeal inlet. The outer cuff shape ensures that the blood flow to the 
laryngeal and perilaryngeal framework is maintained and helps to 
reduce the possibility of neurovascular compression. 
Gastric channel 
The gastric channel runs through the device from its proximal 
opening at the side of the flat connector wing to the distal tip of the non-
inflatable cuff. Since the distal tip of the device fits snugly and 
anatomically correctly into the upper oesophageal opening, the distal 
opening of the gastric channel allows for the passing of a nasogastric 
tube to empty the stomach contents and can facilitate the venting of gas 
from the stomach.  
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Epiglottic rest 
        An artificial epiglottis and a protective ridge help to prevent the 
epiglottis from down-folding or obstructing the distal opening of the 
airway. The epiglottic ridge at the proximal end of the bowl rests at the 
base of the tongue, thus keeping the device from moving upwards out of 
position and the tip from moving out of the upper oesophagus. 
Buccal cavity stabiliser 
        The buccal cavity stabiliser has a built-in natural curvature and an 
inherent propensity to adapt its shape to the oropharyngeal curvature of 
the patient. It is anatomically widened and concaved to eliminate the 
potential for rotation, thereby reducing the risk of malposition. It also 
provides vertical strength to aid insertion. 
SIZE SELECTION15 
I-GEL MAX SIZE OF CETT NASOGASTRIC TUBE WEIGHT 
Size 3 6.0 mm 12G 30-60 kg 
Size 4 7.0 mm 12G 50-90 kg 
Size 5 8.0 mm 14G > 90 kg 
 
Table 1: Various sizes for the I-GEL 
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INDICATIONS 
1. Securing a clear airway in difficult or unexpectedly difficult 
intubations in airway management of an anaesthetised patient. 
2. In a known difficult or unexpectedly difficult intubation, for 
intubating the patient, by passing an endotracheal tube (ETT) 
through the device under fibre-optic guidance. 
3. In a difficult or unexpectedly difficult intubation, to pass a gum-
elastic bougie blindly, but gently, through the device whilst in-situ, 
into the trachea and to rail-road the ETT over it. 
4. Use by the ambulance crew in difficult or unexpectedly difficult 
intubations in a pre-hospital setting in order to quickly establish and 
maintain a clear airway. 
CONTRA-INDICATIONS 
1. Non-fasting patients for routine and emergency anaesthetic 
procedures. 
2. Trismus, limited mouth opening, pharyngeal or perilaryngeal 
abscess, trauma or mass. 
3. Peak airway pressure of ventilation is not allowed to exceed 40cm 
H2O. 
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4. Patients with any condition which may increase the risk of a full 
stomach e.g. hiatus hernia, sepsis, morbid obesity, pregnancy or a 
history of upper gastro-intestinal surgery etc. 
TECHNIQUE OF INSERTION 
The lubricated I-GEL is firmly grasped along the integral bite 
block and the device is positioned so that the I-GEL cuff outlet is facing 
towards the chin of the patient. The patient is positioned in the ‘sniffing 
the morning air’ position with head extended and neck flexed. The chin 
is gently pressed down before proceeding to insert I-GEL.  
The leading soft tip is introduced into the mouth of the patient in a 
direction towards the hard palate. The device is glided downwards and 
backwards along the hard palate with a continuous but gentle push until 
a definitive resistance is felt. After connecting the circuit to I-GEL, 
appropriate placement and ventilation is determined by the chest wall 
movement, auscultation of breath sounds, a square-wave capnograph 
trace and no oropharyngeal leak. 
Excessive force is not applied on the device during insertion. It is 
not necessary to insert fingers or thumbs into the patient’s mouth during 
the process of inserting the device.  
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If there is early resistance during insertion, ‘Jaw thrust’, ‘Insertion 
with deep rotation’, or Triple manoeuvre is tried. After insertion, the tip 
of the airway is located into the upper oesophageal opening and the cuff 
is located against the laryngeal framework.  
An appropriate size endotracheal tube is lubricated and inserted 
through the I-GEL. When the endotracheal tube advances smoothly with 
no resistance, the endotracheal tube cuff is inflated. The endotracheal 
tube adaptor is then attached and the endotracheal tube position is 
confirmed by capnograph. 
 The IGEL is removed using a stabilizing rod, after removing the 
15mm endotracheal tube adaptor and grasping the endotracheal tube 
with fingers. The adaptor is reattached to the endotracheal tube, and the 
ventilation is resumed, and the endotracheal tube position is reconfirmed 
by capnograph. After confirming the endotracheal tube position, the tube 
is secured. 
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INTUBATING LMA 
The classic Laryngeal Mask Airway (LMA) functions both as a 
ventilatory device and as an aid to blind/fibre-optic-guided tracheal 
intubation.         
In 1983, while developing the LMA, Dr. A.I.J. Brain conducted a 
fibre-optic investigation that revealed the LMA’s potential as a guide for 
endotracheal intubation.16  
 
 
 
 
 
 
 
 
Figure 3: The ILMA Device 
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In response to clinicians’ growing demands for a device that had 
the same ventilating properties as the classic LMA but would serve as a 
better conduit for intubation, he designed the Intubating Laryngeal Mask 
Airway (ILMA; LMA of North America, San Diego, CA) which was 
introduced in 1997. This device has better intubating characteristics than 
LMA and eliminates the head and neck manipulation and insertion of 
fingers inside the mouth during placement. 2 
 The device has several features that distinguish it from the classic 
laryngeal mask airway device. The intubating laryngeal mask airway 
consists of a rigid, anatomically curved stainless steel tube 13 mm in 
internal diameter that is connected firmly at its distal end to a soft mask 
that fits over the larynx. 
The angle of the metal shaft was carefully designed using 
measurements from sagittal MRI images, to fit well into the oral and 
pharyngeal space while keeping head and neck in neutral position. 
Proximally the metal shaft forms a standard 15 mm connector for 
the anaesthesia circuit, and a rigid guiding handle serves both to insert 
the device, eliminating the need to insert fingers into the mouth and to 
stabilize and direct the device during intubation attempts. 
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 In addition, the two bars at the aperture of the LMA classic have 
been replaced in ILMA by a single, movable epiglottic elevating bar that 
pushes epiglottis out of the way and allows smooth and unobstructed 
passage of the endotracheal tube as it emerges from the distal end of the 
ILMA’s metal shaft. 
This metal shaft can admit a flexible, reinforced endo-tracheal 
tube (ETT) specifically manufactured for this laryngeal mask. The 
device comes in three sizes for adults (3, 4, and 5), all of which can 
admit a range of ETT sizes, up to 8.0mm in diameter. 
In addition, the shaft of ILMA is shorter than that of the LMA 
Classic, eliminating the need for longer endotracheal tube in patients 
with long neck. 
SIZE SELECTION17 
ILMA size Patients’ weight Cuff volume ETT size 
3 30-50 kg 20 ml 6 
4 50-70 Kg 30 ml 7 
5 70-100 Kg 40 ml 8 
 
Table 2: Various sizes for the ILMA device 
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TECHNIQUE OF INSERTION 
       The device is inserted with the patient's head and neck in neutral 
position2 by using a single-handed operator technique. The lubricated tip 
of the fully deflated mask is placed behind the upper incisor teeth and 
the device is glided downwards and backwards along the hard palate 
with a continuous but gentle push to place it in the hypopharynx. The 
ILMA cuff is then inflated with air (Size 3: 20 ml; Size 4: 30 ml).18  
 After connecting the circuit to the ILMA, appropriate placement 
and ventilation were determined by the chest wall movement, 
auscultation of breath sounds, a square-wave capnograph trace, and no 
oropharyngeal leak. 
The Endotracheal tube 
The tracheal tube recommended by the manufacturer for use with 
the LMA-Fastrach is a silicone, wire-reinforced, cuffed tube with a 
tapered patient end and a blunt tip. This tube is flexible, which allows 
negotiation around the anatomical curves of the airway. It has a high 
pressure, low volume cuff that reduces resistance during intubation and 
makes cuff perforation as the tube passes through the ILMA less likely. 
The design prevents it from retaining the curvature that it assumes by 
passage through the shaft of the ILMA.6 It is reusable and expensive. 
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The lubricated silicone endotracheal tube (7.0mm in females and 
8.0mm in males) designed for blind intubation through the ILMA is 
passed. A transverse marker on the tracheal tube (15 cm) indicates the 
point at which it is about to emerge from under the epiglottic elevating 
bar. 
The endotracheal tube has a longitudinal line, which should be 
oriented to face the patient's nose superiorly. Proper orientation of the 
longitudinal line causes the endotracheal tube to exit the ILMA at an 
angle that eases its passage into the trachea.  
The endotracheal tube also has a circumferential line at a distance 
from the distal tip of the endotracheal tube that is equal to the length of 
the ILMA from the proximal to the distal port. 
 At the point where the circumferential line is advanced to the 
proximal port of the ILMA, the distal tip of the ETT will be in contact 
with the epiglottic elevator bar (which covers the distal port of the 
ILMA). The epiglottic elevator bar raises the epiglottis so that the ETT 
can enter the glottis unimpeded.  
After confirmation of successful endotracheal intubation, the cuff 
of ILMA is deflated and the endotracheal tube connector removed. The 
ILMA is removed while the endotracheal tube is retained in place by the 
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tube stabilizer and the endotracheal tube is grasped with fingers when it 
is visible or palpable. The endotracheal tube connector is reattached and 
ventilation is resumed and the endotracheal tube position is reconfirmed 
by capnograph. 
If resistance is felt, the tracheal tube is withdrawn to one cm 
beyond the epiglottis elevator bar. The following manoeuvres2 were 
used: 
1. Extension manoeuvre 
Pulling the handle back towards the intubator.  
2. Up-down manoeuvre 
Withdrawal of ILMA by 5cm followed by reinsertion. 
3. Optimization manoeuvre 
Manual ventilation performed and position adjusted until optimal 
seal obtained. 
4. Head–neck manoeuvre 
      Flexing of neck and extending the head (not in patients with 
cervical spine pathology) 
5.   Chandy manoeuvre 
         The ILMA is lifted slightly away from the posterior pharyngeal 
wall. 
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Figure 4: The ILMA Device 
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Figure 5: Insertion of the ILMA device and Endotracheal Intubation 
 
 
 
 
 
Figure 6: Removal of the ILMA Device with tube in situ 
 20
THE CHANDY MANOEUVRE 
 
 
 
 
 
 
Figure 7: The Chandy manoeuvre 
 
The Chandy manoeuvre was developed by Dr. Chandy Verghese 
and significantly improves the effectiveness of the ILMA. It incorporates 
two manoeuvres, which are performed sequentially, that improves lung 
ventilation and tracheal intubation using the ILMA.   
1. The first step of the Chandy manoeuvre, which is important for 
establishing optimal ventilation, is to rotate the ILMA slightly  in 
the sagittal plane using the metal handle until the least resistance 
to bag ventilation is achieved, while observing the patient's tidal 
volume and the capnographic waveform (if ventilation is being 
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controlled manually). This helps to align the internal aperture of 
the device with the glottic opening. However, if the patient is 
breathing spontaneously, an airway whistle (e.g., Patil intubation 
guide [Anesthesia Associates, San Marcos, CA]) can be attached 
to the proximal portion of the ILMA to optimize ventilation 
through it. Maximal whistling indicates optimal positioning of the 
ILMA.  
2. The second part of the Chandy manoeuvre is performed just 
before blind intubation and consists of using the metal handle to 
lift slightly (but not tilted) the ILMA away from the posterior 
pharyngeal wall. This facilitates the smooth passage of the 
endotracheal tube into the trachea. This prevents the endotracheal 
tube from colliding with the arytenoids and facilitates the smooth 
passage of the endotracheal tube into the trachea.16 
CONVENTIONAL PVC TUBES 
The laryngeal mask airway (LMA)-Fastrach™ silicone wire-
reinforced tube (FTST) was designed for tracheal intubation through the 
intubating LMA (ILMA). It is reusable and expensive.  
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The conventional polyvinyl chloride (PVC) tracheal tube is stiff 
and emerges from the ILMA with its distal end pointing too much to the 
anterior to have a chance of entry into the glottis.9 
 
 
 
Figure 8: Comparison of emerging angle of FTST, PVC and LAT tubes 
However, despite the cited advantages of the FTST, conventional 
PVC tubes are being used successfully for blind tracheal intubation 
through the ILMA. 
The Rusch PVC tracheal tube (PVCT) is meant for single use and 
is much less expensive. Warming a plastic tube will result in success and 
complication rates similar to that of the tube from the LMA-Fastrach 
manufacturer.19 
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a = straight silicone tube, 8 mm 
b = curved Euromedical polyvinyl chloride tube 
(PVC), 8 mm 
c = Rusch red rubber, 8 mm 
d = Portex PVC, 8 mm 
e = Mallinkrodt PVC, 8 mm 
f  = Mallinkrodt PVC reinforced, 7 mm 
g = Rusch PVC 7-mm prewarmed tube (40°C) 
h = Rusch PVC 7 mm at room temperature (27°C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Effect of tracheal tube curvature for different tubes  at 25°C (•) and 37°C (★)  
when passed through the intubating laryngeal mask airway. 
 
While using the curved PVC tracheal tube, it may be helpful to 
orient the curve opposite the ILMA curve.9, 20 Whatever the tracheal tube 
is used, it is essential that it is possible to remove the connector.21 It is 
important to lubricate the tracheal tube well and pass it through the 
ILMA several times before use.22 
The PVC tracheal tube is inserted with its natural curve along the 
ILMA curvature and in the reverse direction. As a result, the angle at 
which the tip of the tracheal tube emerged from the intubating LMA is 
47° or 20°, respectively. 9, 20, 23 
 24
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Comparison of emerging angle with orientation of the tracheal tube 
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REVIEW OF LITERATURE 
P. Michaleka et. al. 24 (Resuscitation 2010; 81: 74–77)  
Michaleka et. al. evaluated the success rate of blind intubation 
(using a gum-elastic bougie, an Aintree intubating catheter (AIC) and 
designated tracheal tube) and fiberscope guided tracheal intubation 
through the intubating laryngeal mask airway and the I-GEL supraglottic 
airway on three different airway  manikins. 
Twenty-five anaesthetists performed three intubations with each 
method on each of three manikins. The success rate of the fibre-optic 
guided technique was significantly higher than blind attempts (P < 
0.0001) with both devices. For fibre-optic techniques, there was no 
difference found between the ILMA and I-GEL (P > 0.05). All blind 
techniques were significantly more successful in the ILMA group 
compared to the I-GEL (P < 0.0001). They concluded that, in manikins, 
fibre-optic intubation through both ILMA and I-GEL is a highly 
successful technique. Blind intubation through the I-GEL showed a low 
success rate and should not be attempted.    
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Dr. Neerja Bharti, Dr. Asit Kumar Naik25  (Indian J Anaesthesia - 
2006; 50(3): 205-208) 
Dr. Bharti and Dr. Naik compared the ease of insertion and 
haemo-dynamic effects following tracheal intubation through intubating 
laryngeal mask airway (ILMA). Eighty adult patients undergoing 
elective surgery were randomly allocated into two equal-sized groups. 
Tracheal intubation was performed using either intubating laryngeal 
mask airway or Macintosh laryngoscope. Time to intubation was 
comparatively longer in ILMA group than laryngoscopy group. The 
overall intubation success rate was comparable among the groups. The 
changes in blood pressure were significantly less in ILMA group as 
compared to laryngoscope group (p<0.05). Their results suggested that 
ILMA offers advantage over laryngoscope in minimizing the 
haemodynamic effects to intubation. Therefore, it can be used as a 
suitable alternative to laryngoscopy for tracheal intubation. 
Pankaj Kundra, Sujata N, Ravishankar M.19 (Anesth Analg 
2005;100:284–8) 
They evaluated the success rate of blind tracheal intubation 
through the ILMA by using the Fastrach™ silicone wire-reinforced tube 
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(FTST), the Rusch polyvinyl chloride tube (PVCT), and the Rusch latex 
armoured tube (LAT). They divided 150 patients into three groups. 
FTST (n = 50), pre-warmed PVCT (n = 50), and LAT (n = 50) were used 
for tracheal intubation. Significantly more frequent success in tracheal 
intubation was achieved with the PVCT and FTST compared with the 
LAT. Tracheal intubation on the first attempt was similar with the PVCT 
and FTST (86%) and was significantly more frequent than with the LAT 
(52%) (P<0.05).  Esophageal placement was significantly more frequent 
with the LAT when compared with the PVCT and FTST. The authors 
concluded that a pre-warmed PVCT can be used as successfully as the 
FTST for blind tracheal intubation through the ILMA, whereas the LAT 
was associated with more frequent failure and oesophageal intubation. 
Tao Zhu, MD et al.23 (Anaesthesia Analgesia 2007; 104: 213-214) 
Dr. Zhu described insertion of Mallinckrodt polyvinyl chloride 
(PVC) endotracheal tubes into the intubating laryngeal mask airway 
(ILMA) with the curvature aligned with the ILMA versus rotated 180° 
from the intrinsic curvature of the ILMA. He found that the non-
intuitive 180° rotation yielded a higher success rate, confirming 
previous findings of Joo and Rose. Since the emergence angle changed 
from 20° to 40° when mild force was applied, they suggested pre-
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warming the endo-tracheal tube to render it more flexible and avoiding 
undue application of force. The rate of successful tracheal intubation 
was likely to increase, accompanied by a lower incidence of airway 
trauma and sore throat.  
Ryu Komatsu et al.26 (Br. J. Anaesth 2004; 93 (5): 655-659) 
They tested the hypothesis that the ILMA facilitates tracheal 
intubation even in patients wearing a rigid cervical collar. They 
performed blind tracheal intubation via an ILMA in 50 cervical spine 
surgery patients with a rigid Philadelphia collar in place and 50 general 
surgery patients under general anaesthesia. There were no significant 
differences between the collar and control patients in terms of total time 
required for intubation, number of intubation attempts, overall 
intubation success rate, or the incidence of intubation complications. 
Blind intubation through an ILMA was thus a reasonable strategy for 
controlling the airway in patients who are immobilized with a rigid 
cervical collar, especially when urgency precludes a fibre-optic 
approach. 
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A.N.Shetty et. al.27 (The Internet Journal of Anesthesiology 2006; 10(2)) 
They performed blind endotracheal intubation through ILMA in 
75 patients. In spite of 32% of patients having restricted and nil neck 
movements, ILMA was inserted in 76% and 20% patients in first 
attempt and second attempt respectively. They could successfully 
intubate through ILMA in 96% patients with 58% in the first attempt. 
Haemodynamic parameters were clinically not significant. They 
concluded that ILMA is a useful tool in patients with anticipated 
difficult airway especially in patients with cervical spine pathology and 
blind endotracheal intubation through ILMA was easy. 
Theiler, Lorenz G. et. al.28 (Anesthesiology 2009; 111 (1): 55-62) 
This randomized controlled trial was performed in a simulated 
difficult airway scenario using an extrication collar limiting mouth 
opening and neck movement to compare the clinical performance of 
LMA-Supreme™ and I-GEL™. They concluded that both airway 
devices had similar insertion success and clinical performance in the 
simulated difficult airway situation. The authors found less epiglottic 
downfolding and better fibre-optic view but longer insertion time with 
the I-GEL™. Their study showed that both devices are feasible for 
emergency airway management in patients with reduced neck movement 
and limited mouth opening. 
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Hwan S. Joo and D. Keith Rose,9 (Anesth Analg 1999; 88: 662–6) 
They compared the blind and the fibre-optic tracheal intubation 
using the intubating laryngeal mask airway (ILMA). After a 
standardized inhaled anaesthesia induction protocol, tracheal intubation 
using ILMA with fibre-optic guidance (ILMA-FOB) and without fibre-
optic guidance (ILMA-Blind) was compared with the control group of 
direct laryngoscopy (laryngoscopy group). For tracheal intubation, 
success rates were equal in all three groups. Total intubation time was 
longer for the ILMA-FOB group (77 s versus 48.5 s for laryngoscopy 
and 53.5 s for ILMA-Blind). They concluded that the success rate was 
equally high for tracheal intubation using ILMA-Blind and ILMA-FOB 
techniques. They stated that ILMA can be used as a primary airway for 
oxygenation and ventilation. Both methods of tracheal intubation using 
the ILMA were equally successful and suitable alternatives to 
laryngoscopy for tracheal intubation. 
Pavel Michalek, MD, PhD, et al.14 (Anesth Analg 2008; 106: 1501–4) 
They described the successful fibre-optic-guided tracheal 
intubation through “I-GEL” airway in two uncooperative adult patients 
with genetic syndromes, learning disability, and predicted difficult 
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airway, scheduled for complex dental treatment under general 
anaesthesia. I-GEL maintained the airway immediately after induction, 
allowing oxygenation and ventilation. Location of the laryngeal inlet 
was successful on the first attempt with a fiberscope, and the tracheal 
tube was inserted into the trachea over the endoscope without 
complication in both patients. This report suggested another option for 
management of predicted difficult airways. 
Gatward JJ.et.al 29 (Anaesthesia 2008; 63(10): 1124-30) 
They studied the I- GEL in 100 elective, anaesthetised patients. 
First insertion attempt was successful in 86 patients, second attempt in 
11 patients, and third attempt in three patients. Median insertion time 
was 15 s. On fibreoptic examination via the device, vocal cords were 
visible in 87 patients (91%). The I-GEL was easily and rapidly inserted, 
providing a reliable airway in over 90% of cases. 
Sharma S, Rogers R, Popat M.13(Anaesthesia 2007; 62: 412-423) 
A teenage male patient was scheduled for closure of a colostomy. 
A size 4 IGEL airway was placed and ventilation was satisfactory. After 
confirmation of a good view of the vocal cords with a 4.1-mm adult 
fibreoscope, a size 6.5 mm cuffed tracheal tube was successfully passed 
through the stem of the IGEL blindly into the trachea at the first attempt. 
The IGEL was left in place until extubation. 
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L. de Lloyd et.al.30 (Anaesthesia, 2010; 65: 36–43) 
They compared the classic laryngeal mask airway and IGEL as 
adjuncts to fibrescope guided intubation in a manikin. They concluded 
that the IGEL was likely to be a more appropriate conduit than the 
classic laryngeal mask airway for fibrescope guided intubation. 
R. M. Levitan 12(Anaesthesia 2005; 60: 1022–1026)  
They studied the positioning and mechanics of IGEL in 65 non-
embalmed cadavers with 73 endoscopies, 16 neck dissections, and six 
neck radiographs. A full view of the glottis (percentage of glottic 
opening score 100%) occurred in 44⁄73 insertions, whereas only 3⁄73 
insertions had epiglottis-only views. Including the eight repeat insertions 
with a different size, a glottic opening score of > 50% was obtained in 
all 65 cadavers. The mean percentage of glottic opening score for the 73 
insertions was 82%. In each of the neck dissections and radiographs, the 
bowl of the device covered the laryngeal inlet. They found that the I-
GEL effectively conformed to the perilaryngeal anatomy despite the 
lack of an inflatable cuff and consistently achieved proper positioning 
for supraglottic ventilation. 
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MATERIALS AND METHODS 
STUDY DESIGN 
This study was a single blind, randomized, prospective 
comparative study conducted in Government Stanley Medical College 
and Hospital, Chennai.  
STUDY SETTING AND POPULATION: 
The Institutional Ethical committee approval was obtained before 
commencement of the study. Written informed consent was obtained 
from all the patients. Eighty adult patients of ASA Physical status 1& 2 
of either sex undergoing elective surgical procedures under general 
anaesthesia were enrolled in the study.  
The study was conducted at the General Surgery theatre complex, 
Stanley Medical College and Hospital, Chennai. The study was 
conducted from January 2010 to October 2010. The supraglottic airway 
device insertion and blind tracheal intubation was done by the author. 
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PATIENT SELECTION 
Inclusion criteria: 
¾ Age 20 to 50 years 
¾ Both sexes 
¾ Weight 40-70 kg. 
¾ Mallampatti 1 & 2 
¾ ASA physical status 1-2 
¾ Patients undergoing elective surgery under general anaesthesia, 
requiring endotracheal intubation  
Exclusion Criteria 
¾ Patients with limited mouth opening (less than 2 cm) 
¾ Anticipated difficult airway. 
¾ Patients at increased risk of aspiration, or having a history of 
symptomatic gastro-esophageal reflux or hiatus hernia. 
¾ Symptoms related to laryngo-pharyngeal anomaly. 
¾ Musculoskeletal abnormalities affecting the cervical vertebrae. 
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MATERIALS: 
¾ Intubating Laryngeal mask airway (ILMA) 
¾ I-GEL 
¾ Endo-tracheal tube 
¾ IV cannulae, 
¾ Monitors 
¾ Drugs for general anaesthesia 
STUDY METHOD: 
After obtaining ethical committee approval, the patients were 
randomized into one of the two groups using a closed envelope method 
with predetermined group numbers and then single-blinded.  
¾ Group A: I-GEL for airway management 
¾ Group B: ILMA for airway management 
Patients were advised for preoperative overnight fasting for 8 
hours. They were given aspiration prophylaxis with Tab Ranitidine 150 
mg and Tab Metoclopramide 10 mg on the night before surgery and Inj. 
Glycopyrrolate 5mcg/kg im, one hour before induction. 
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Standard monitoring was applied before induction and included 
ECG, pulse oximeter, capnography and Non-invasive Blood pressure 
monitor, temperature monitoring, neuromuscular monitoring. 
Intravenous access was obtained with 18G peripheral venous 
cannula in the forearm. The patient was placed in supine position with 
the patient’s head on a pillow of 10cms height. 
 Pre-oxygenation was done for 3 minutes with 100% oxygen. All 
patients were given Inj. Midazolam 0.02mg/kg iv, Inj. Fentanyl 2 
mcg/kg iv. Anaesthesia was induced with Inj. Propofol 2mg/kg iv and 
Inj Atracrurium 0.5 mg /kg iv. The patients’ lungs were manually 
ventilated by face mask with 2% Sevoflurane in oxygen for 3 minutes. 
An appropriate size supraglottic airway device was then inserted by the 
author.  
Group A (I-GEL) 
The patient was positioned in the ‘sniffing the morning air’ 
position with head extended and neck flexed. The chin was gently 
pressed down before proceeding to insert I-GEL. 
 37
The lubricated I-GEL was firmly grasped along the integral bite 
block and the leading soft tip was introduced into the mouth of the 
patient in a direction towards the hard palate. 
The device was glided downwards and backwards along the hard 
palate with a continuous but gentle push until a definitive resistance was 
felt. After connecting the circuit to the IGEL, adequate placement of the 
device was confirmed with chest wall excursions, square wave 
capnography and no oropharyngeal leak.  If there was early resistance 
during insertion, the following manoeuvres were tried: (a) Jaw thrust, 
(b) Insertion with deep rotation, and (c) Triple manoeuvre. 
An appropriate size conventional PVC endotracheal tube was 
lubricated and inserted through IGEL with the endotracheal tube 
inserted backward, such that the concave bend was facing down. When 
the endotracheal tube was advanced smoothly with no resistance, the 
endotracheal tube cuff was inflated and ventilation confirmed by 
capnograph. 
An intubation attempt was considered successful, if the tracheal 
tube was advanced smoothly without resistance and a positive 
capnographic tracing was obtained. 
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 The 15mm endotracheal tube adaptor was removed. The I-GEL 
was removed after stabilising the tube using a stabilizing rod and by 
grasping the endotracheal tube with the fingers.  
After attaching the adaptor to the endotracheal tube, the 
ventilation was resumed, and the endotracheal tube position was 
reconfirmed by chest wall movement, auscultation of breath sounds, a 
square-wave capnograph trace. 
A “failed intubation attempt” was considered when tactile 
resistance was felt while advancing the tracheal tube or esophageal 
intubation. 
The second attempt was made with the reinsertion of either the 
same or different size IGEL and after optimising ventilation, the tracheal 
intubation was attempted through the device. 
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Figure 11: Insertion Technique for I-GEL 
 
 
 
     
 
 
 
 
 
 
 
Figure 12: Manoeuvre for Insertion of  I-GEL     
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Group B (ILMA) 
An ILMA was inserted into the hypopharynx with the head–neck 
in the neutral position, and the cuff was inflated with air up to the 
maximum recommended volume (20 ml in size 3 and 30 ml in size 4). 
Adequate ventilation was assessed by chest wall movement, capnograph 
waveform during manual ventilation.  
If adequate ventilation was not attained, the ILMA was 
manipulated (Chandy’s manoeuvre- step1) in situ. If the ventilation was 
not achieved in the first attempt, the same ILMA device was either 
reinserted or change of ILMA size was done during subsequent attempt 
and optimal ventilation was confirmed.  
The point at which the tracheal tube is about to emerge from the 
epiglottic elevating bar was noted on the endotracheal tube before 
insertion. An appropriate size conventional PVC endotracheal tube 
(without 15mm connector) was inserted through ILMA with the 
endotracheal tube inserted backward, such that the concave bend was 
facing down. 
 
    
 41
 
 
 
 
 
Figure 13: Effect of endotracheal tube curvature on intubation through ILMA 
  
If resistance was encountered during passage of the tracheal tube, 
the tracheal tube is withdrawn to one cm beyond the epiglottic elevator 
bar and “Chandy’s manoeuvre step-2” was performed and further 
advancement of the tube was attempted. 
An intubation attempt was considered successful, if the tracheal 
tube was advanced smoothly without resistance beyond 15cms and a 
positive capnographic tracing was obtained. The endotracheal tube 
adaptor was removed. The ILMA was then removed after deflating the 
cuff and stabilizing the endotracheal tube with the stabilizing rod and 
grasping the tube with fingers once visible. The endotracheal tube 
adaptor was reattached and ventilation was reconfirmed by 
capnography. 
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A “failed intubation attempt” was considered when (i) tactile 
resistance was still felt while advancing the tracheal tube despite the 
adjusting manoeuvres (ii) the tracheal tube was advanced the full 
distance, but no capnographic tracing was seen (esophageal intubation). 
The second attempt was made with the reinsertion of either the 
same or different size ILMA and after optimising ventilation, the 
tracheal intubation was attempted through the device. 
In both the groups, intubation through the supraglottic airway 
device was limited to two attempts. Intubation failure was recorded if, 
despite two attempts, repeated tactile resistance or esophageal intubation 
were encountered. When intubation was unsuccessful after two attempts, 
the procedure was abandoned, and tracheal intubation was performed 
under direct laryngoscopy.    
Primary outcome measure was first attempt success rate for blind 
endotracheal intubation between IGEL and ILMA.  Other outcome 
measures include total time required for tracheal intubation and ease of 
insertion of supraglottic airway device. 
Ease of insertion of the supraglottic airway device would include 
number of attempts and time required for insertion of the device. 
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 “Supraglottic Airway Device insertion time” was defined as the 
time from removal of the face mask to the time ventilation was 
established through the supraglottic airway device with CO2 
confirmation. 
“Tracheal intubation time” was defined as the time from loss of 
CO2 due to disconnection of the circuit from the supraglottic device to 
the time of reappearance of the CO2 from the tracheal tube with no 
evidence of cuff leak with positive pressure ventilation.  
Intubation failure was recorded if, despite two attempts, repeated 
tactile resistance or esophageal intubation were encountered. Patients 
with unsuccessful intubation were excluded from the analysis of total 
intubation time.  Number of failed attempts at intubation was also noted 
Ease of removal of supraglottic airway device after establishing 
tracheal intubation was noted by the time taken to remove the device 
(time from insertion of pusher to reconnection of breathing circuit to the 
tracheal tube). Any critical incident during device removal, such as 
accidental extubation or tube displacement was noted. 
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The heart rate and oxygen saturation were recorded continuously 
and blood pressure was recorded after induction,1 minute and 5 minutes 
after successful tracheal intubation and then at every 5 minutes till the 
end of surgery. 
Any problem encountered during intubation was recorded. 
Complications such as saturation < 95%, dental trauma, esophageal 
intubation, laryngospasm, blood staining of the device (mucosal 
trauma), lip or dental injury were looked for. 
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OBSERVATION AND RESULTS 
 
Eighty patients of either sex belonging to ASA PS 1 & 2, 
undergoing elective procedures under general anaesthesia were studied. 
The data were collected and analyzed with SPSS Version 15 (SPSS Inc., 
Chicago, IL). 
 Demographic data and the time taken for device placement, 
tracheal intubation and device removal among the groups were analyzed 
with unpaired t test. Chi-square analysis was used for comparing sex and 
the number of attempts required for intubation through the supraglottic 
device insertion. 
Chi square analysis with Yates’ continuity correction was applied 
to compare the number of attempts required for supraglottic device 
insertion and success and failure rate for intubation. Paired t test was 
used to compare the hemodynamic response at 1minute after intubation 
from the baseline values within the group. Unpaired t test was used to 
compare the hemodynamic response to intubation in between the 
groups. p < 0.05 was considered statistically significant.  
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AGE DISTRIBUTION:       
GROUP N MEAN (Years) S.D p value 
I-GEL 40 29.17 5.47 
p=0.693 
ILMA 40 28.65 6.33 
 
Table 3: Age distribution of patients in the two groups 
 
The mean age in both the groups was around 29 years. Both 
groups were comparable with regard to age and there was no statistically 
significant difference between the two groups. (p=0.693) 
WEIGHT DISTRIBUTION: 
GROUP N MEAN (Kg) S.D 
Student’s t- test 
p value 
I-GEL 40 60.82 7.44 
t =0.30 
 
p =0.976 ILMA 40 60.77 7.62 
 
Table 4: Weight Distribution 
 
Both groups were comparable in terms of weight, the average 
weight being similar - around 60 kg in both groups. In both the groups, 
majority of the patients were in the range of 61-70 Kg. Six patients in 
the IGEL and five in the ILMA were in the range of 40-50 Kg. 
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Figure- 14:  Weight Distribution 
 
COMPARISON OF SEX DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
 
                                          Figure-15:  Sex distribution  
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In ILMA group, 16 were male and 24 were female. In IGEL 
group, 15 were male and 25 were female. No significant difference was 
found between the two groups in terms of gender distribution. Chi 
square analysis: X2 = 0.53; p=0.818 (not significant). 
SUPRAGLOTTIC AIRWAY DEVICE AND ENDOTRACHEAL 
TUBE SIZE 
SIZE 
I-GEL ILMA TOTAL 
Device ETT (mm I.D.) 
3 6 12 10 22 
4 7 28 30 58 
TOTAL 40 40 80 
 
Table 5: Supraglottic device and ETT size used in both groups 
 
The size of the supraglottic airway device used in both the groups 
in the study was 3 and 4. Size 4 was predominately used in both the 
groups, 30 patients in ILMA group and 28 in I-GEL group. Size 4 was 
used in patients with weight 50 – 70 Kg in ILMA group and 50-90 kg in 
IGEL group. In our study, most of the patients’ weight was in the range 
of 50–70 Kg. The size 3 and 4 supraglottic airway devices 
accommodated 6 mm I.D and 7 mm I.D endotracheal tubes respectively. 
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SUPRAGLOTTIC DEVICE INSERTION TIME 
GROUP N MEAN (SECONDS) SD P value 
I-GEL 40 15.62 2.65 
t =2.955 
p =0.004* 
ILMA 40 17.17 1.98 
  * Statistically significant 
Table 6: Device insertion time (in seconds) for both groups 
 
 
 
 
 
 
 
 
 
 
 
 
Figure – 16 Supraglottic Device Insertion Time 
 
The least time required for I-GEL placement was 10 seconds in 
one patient versus 14 seconds in ILMA group. The maximum time 
required for a single attempt of placement of the device was 18 seconds 
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in I-GEL and 20 seconds in ILMA. The average time taken for the 
placement of I-GEL (15.62± 2.65 seconds) was significantly less when 
compared with ILMA (17.17 ±1.98 seconds). (P<0.05) 
NUMBER OF ATTEMPTS FOR SUPRAGLOTTIC DEVICE  
INSERTION 
GROUP 
NO. OF  ATTEMPTS 
TOTAL 
CHI-SQUARE 
YATES’ 
CORRECTION 1 2 
IGEL 
36 4 40 
X2=0.180 
p=0.671 
90% 10% 100% 
ILMA 
38 2 40 
95% 5% 100% 
 
Table 7: Number of attempts for supraglottic device insertion 
 
Both the devices were placed successfully in the first attempt in 
90% of patients in IGEL group and 95% of patients in ILMA group. 
Insertion and effective ventilation through both devices were possible in 
all cases in both the groups. In I-GEL group, in three patients, the size 4 
device was replaced with size 3. In one patient the same device was 
repositioned with jaw thrust during second attempt. In patient with body 
weight in the range of 50 to 60 kg, I-GEL of size 3 and 4, both can be 
used, so the size selection was at the discretion of the anaesthesiologist. 
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NUMBER OF ATTEMPTS FOR SUPRAGLOTTIC DEVICE PLACEMENT
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In ILMA group, during second attempt, two patients required 
device repositioning and adjusting manoeuvre (Chandy manoeuvre: step 
1) to achieve adequate ventilation. There was no significant difference 
between the two groups in the number of attempts for insertion of 
supraglottic airway device. (p= 0.671) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17: Attempts for supraglottic device placement 
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TIME FOR FIRST ATTEMPT TRACHEAL INTUBATION 
GROUP N MEAN (seconds) SD 
Student’s 
t-test 
p value 
I-GEL 24 15.88 2.49 
t =0.584 
p =0.5611 
ILMA 35 16.31 3.04 
 
Table 8: Time for First attempt Tracheal intubation 
 
The mean time for successful first attempt tracheal intubation was 
15.88 seconds and 16.31 seconds in I-GEL and ILMA group 
respectively. There was no statistical significant difference between the 
two groups.  
 NUMBER OF ATTEMPTS FOR SUCCESSFUL TRACHEAL 
INTUBATION 
GROUP 
NO.OF ATTEMPTS 
TOTAL 
CHI-SQUARE 
YATES’ 
CORRECTION 1 2 FAILURE 
IGEL 
24 5 11 40 
X2=8.78 
p= 0.0124* 
60% 12.5% 27.5% 100% 
ILMA 
35 3 2 40 
87.5% 7.5% 5% 100% 
* Statistically significant 
Table 9: Number of attempts for successful tracheal intubation 
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Among 35 patients who were intubated in first attempt, 28 didn’t 
require any manoeuvre and 7 required Chandy manoeuvre step 2 just 
before intubation.  
Three patients were intubated in second attempt in ILMA group 
despite adequate ventilation achieved through the device during the 
initial placement. In one patient, resistance to tube was observed at 2cms 
from the transverse mark, and down-folding of epiglottis might be a 
reason and hence the same device was reinserted with jaw thrust to 
prevent epigottic down-folding.  
In the other two patients, esophageal intubation occurred in the 
first attempt and the size 4 was large and replaced with size 3 and both 
were intubated successfully in second attempt. Despite Chandy 
manoeuvres and reinsertion of device, repeated esophageal intubation 
was recorded in 2 patients in the ILMA group who were subsequently 
intubated successfully under direct laryngoscopy. Both of them had 
Cormack Lehane laryngeal view 1 under direct laryngoscopy. 
  Intubation was successful through the I-GEL in first attempt 
without any manoeuvre in 24 patients and second attempt in 5 patients. 
In two patients, oesophageal intubation occurred during the first attempt.  
 54
During second attempt, the device was removed and reinserted 
and intubated successfully. In two patients, tactile resistance was felt, 
and smaller size endotracheal tube was used for subsequent successful 
intubation. In another patient, size 4 was replaced with size 3 and 
subsequently intubated. 
FIRST ATTEMPT SUCCESS RATE FOR TRACHEAL 
INTUBATION 
First attempt success rate was high in ILMA group with 87.5% 
while only 60% in I-GEL group. Chi-square test: x2=7.813; p=0.005. 
There was a statistical significant difference between the two groups. 
(p<0.05) 
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          Figure-18: First attempt success rate for tracheal intubation 
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Figure 19: Number of intubation attempts for the I-GEL 
 
 
 
 
 
 
 
 
 
 
Figure 20: Number of intubation attempts for the ILMA device 
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SUCCESS AND FAILURE RATE FOR INTUBATION 
GROUPS 
INTUBATION  ATTEMPT 
TOTAL 
SUCCESS FAILURE 
 
I-GEL 
 
29 11 40 
72.5% 27.5% 100% 
 
ILMA 
 
38 2 40 
95% 5% 100% 
 
Table 10: success and failure rate for intubation  
 
 Chi Square test with Yates’ correction was applied and x2=5.878;      
p=0.0153 (statistically significant) 
 
 
 
 
 
 
Figure 21: Success and failure rate of intubation for both I-GEL and ILMA 
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The overall success rate for intubation was significantly higher in 
ILMA group (95%) than in the I-GEL group(72.5%). We failed to 
intubate in eleven patients in the I-GEL group and two in the ILMA 
group. Subsequently they were intubated using direct laryngosopy 
(macintosh). Those patients who required direct laryngoscopy had a 
Cormack Lehane grade 1 and 2 laryngeal view and the airway anatomy 
appeared normal. 
SUPRAGLOTTIC DEVICE REMOVAL TIME: 
GROUP N MEAN (seconds) S.D 
Student’s 
t-test 
p value 
I-GEL 40 15.82 1.61 t=2.079 
 
p=0.041* ILMA 40 16.55 1.50 
* Statistically significant 
Table 11: Supraglottic device removal time 
 
The average time for I-GEL removal after intubation was 
significantly less than ILMA (p<0.05). There was no incidence of 
accidental extubation or tube displacement while removing the device.  
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TOTAL TIME FOR INTUBATION (INCLUDING DEVICE 
REMOVAL) IN SUCCESSFUL INTUBATION 
GROUP N MEAN (seconds) S.D 
Student’s 
t-test 
p value 
I-GEL 29 49.69 6.68 t = 0.918 
p = 0.3621 ILMA 38 51.13 6.13 
 
Table 12: Total time for tracheal intubation 
 
The mean total time for successful intubation (including the 
device removal) was 51.13 ± 6.13 seconds for ILMA and 49.69 ± 6.68 
seconds for I-GEL. The mean total time would include the time required 
for supraglottic device insertion, successful tracheal intubation and 
supraglottic device removal. There was no statistical difference between 
both the groups in respect to total time required for intubation (including 
device removal). (P>0.05) 
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COMPLICATIONS: 
VARIABLES I-GEL ILMA 
Saturation <95% 0 0 
Dental Trauma 0 0 
Oesophageal Intubation 12 4 
Laryngospasm 0 0 
Mucosal Trauma 6 5 
 
Table-13: Complications during Intubation 
The incidence of oesophageal intubation was more with I-GEL in 
comparison with ILMA. The blood staining of the device was noted and 
it was an indication of mucosal trauma. Six patients in I-GEL group had 
mucosal trauma against five patients in ILMA group. 
HEMODYNAMIC RESPONSE 
 The increase in systolic blood pressure, diastolic blood pressure 
and mean arterial pressure from the baseline values were insignificant 
(p>0.05) at one minute after tracheal intubation in both the groups. 
When compared among the groups, there was no significant difference 
in the increase in blood pressure (systolic, diastolic, mean arterial 
pressure) from the baseline values. 
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 In both the groups, there was a significant (p<0.05) increase in 
heart rate at one minute after intubation from the baseline values. 
Among the groups, there was no significant difference between the 
increase in heart rate at 1 min after intubation from the baseline values. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Changes in Systolic & Diastolic blood pressure before & after intubation in 
I-GEL and ILMA  
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Figure 23: Changes in Mean Arterial Pressure (MAP) before and after tracheal 
intubation  
 
 
 
 
 
 
 
 
Figure 24: Variation in Heart Rate while using I-GEL and ILMA 
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DISCUSSION 
The mean age, weight and sex ratio were comparable in both the 
groups. Our study showed that the I-GEL, as a ventilatory device was as 
effective as ILMA in maintaining the ventilation and oxygenation in the 
anaesthetized patients with normal airway.  
The mean insertion time for supraglottic airway device was 
significantly less for I-GEL in comparison with ILMA. The I-GEL being 
an uncuffed peri-laryngeal sealer, the insertion was easy and quick. It 
also provided a reliable airway.   
Both IGEL and ILMA were successfully inserted in all patients. 
The overall success rate for supraglottic airway device insertion was 
similar in both the groups. The result obtained with IGEL was 
comparable with that obtained by Gatward.J.et.al.29 The device was 
inserted in first attempt in 36 patients in IGEL and 38 patients in ILMA 
with no significant difference.  
Choosing the size of supraglottic airway device was more 
important as inappropriate sizing could lead to significant reduction in 
first attempt success rate for insertion of the device. The size of the 
supraglottic airway device predominantly used in the study was 4, as 
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majority of the patients’ weight were in the range of 50- 70 kg. There 
were no adverse airway events recorded during placement of the 
supraglottic airway device.  
The overall success rate of blind endotracheal intubation through 
ILMA with conventional PVC tubes with curvature facing downwards 
in patients with Mallampatti 1&2 was 95% and was significantly higher 
than in I-GEL (72.5%). Joo & Rose9 reported 96.7% overall intubation 
success rate with reverse orientation of conventional PVC tracheal tubes 
through ILMA in patients with normal airway.  
 Kundra et.al.19 demonstrated a 96% success rate within two 
intubation attempts with both Rusch PVC tubes oriented in normal 
direction and with silicone wire-reinforced tubes. 
Michalek.et.al.24 compared the IGEL and ILMA as a conduit for 
tracheal intubation in manikin and concluded that the success rate for 
blind tracheal intubation through ILMA was over 80% and IGEL was 
63%.  
The first-attempt success rate is another important performance 
indicator for tracheal intubation.  The first attempt success rate of blind 
endotracheal intubation through ILMA was 87.5% similar to that 
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obtained by Joo.et.al 9 and through I-GEL was 60%. The first attempt 
success rate of blind endotracheal intubation was significantly high in 
the ILMA.  
The curved shape of the ILMA stem which directs the tube 
anteriorly,6 and the adjusting Chandy manoeuvre of ILMA used before 
intubation probably improved the success rate. 16 
An important factor that determines the success rate of tracheal 
intubation is the angle at which the tracheal tube emerges from the distal 
aperture of the ILMA2 and IGEL. Tracheal intubation via an ILMA with 
the conventional tracheal tube inserted in reverse orientation was first 
described by Joo and Rose9. The reverse orientation of the conventional 
PVC endotracheal tubes through ILMA reduced the emerging angle of 
the tube from the ILMA (from 40º to 20º)9,20,23 and improved the success 
rate of intubation even though the silicone reinforced tube was not used. 
More failure in blind intubation attempts were recorded in I-GEL 
group. P. Michalek et.al.24 had observed the same findings in his study. 
The incidence of the esophageal intubation was common with I-GEL. 
The reason attributed to this was the relatively straight shape of the I-
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GEL stem which has a tendency to direct them posteriorly and thus 
increase the risk of oesophageal intubation or snaring on the arytenoids. 
Joo et.al.9 had cited that inappropriate positioning of the ILMA in 
relation to the glottis, as assessed by fibre-optic view, as the reason for 
an increase in the number of attempts and the incidence of failure to 
achieve tracheal intubation.  
The mean time required for successful tracheal intubation in first 
attempt was similar in both the groups. Anitha shetty.et.al27 had obtained 
similar results with ILMA. 
The IGEL has a wider stem. Danha et.al31 suggested that wider 
shaft of the channel and absence of bar make the tube passage 
‘subjectively easy’.  
The time required for the supraglottic device removal after 
intubation was significantly less in the I-GEL group. This uncuffed 
device was easier to remove with endo-tracheal tube in situ using a 
stabilizing rod. Sharma et.al.13 described difficulties in removing the 
IGEL after intubation, but we have not noted any significant difficulties 
by using the silicone stabilising rod from the ILMA set. 
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The total time required for successful endo-tracheal intubation 
(including Airway insertion time, intubation time and removal of airway 
device) was equal in both the groups showing no statistical significant 
difference. The average total time for successful intubation through 
ILMA was 51.13 ± 6seconds and for I-GEL was 49.69 ± 6 seconds.  Joo 
et.al9 had similar total intubation time (from induction to tracheal 
intubation with exclusion of device removal) with 53.5s for blind 
endotracheal intubation.   
The heart rate response to intubation at one and five minutes was 
significantly high when compared with the pre-intubation values within 
the group. Among the groups, the heart rate response to intubation is 
significantly high in the I-GEL group.  
The blood pressure response to intubation recorded at one minute 
after intubation was insignificant when compared with the baseline 
values within the group. Among the groups, there was no significant 
difference in the blood pressure response to intubation at 1 minute after 
intubation from the baseline values. There was significant increase in 
the heart rate recorded at one minute after intubation in both the groups 
but when compared between the groups, there was not much of 
statistical significance. 
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There was no incidence of oxygen de-saturation in both the 
groups. This study had showed that both the I-GEL and ILMA 
effectively maintain ventilation and oxygenation. Incidence of mucosal 
trauma (blood staining of the device) and oesophageal intubation were 
more with IGEL in comparison with ILMA. There was no incidence of 
laryngospasm or dental trauma in both the groups.   
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SUMMARY 
Insertion of supraglottic airway and tracheal intubation through it 
may be indicated where conventional laryngoscopy fails. The ILMA 
was specially designed for this purpose.  IGEL, a relatively new device 
has some benefits: disposable, cheap & its wide bore facilitate direct 
passage of a standard size tracheal tube. It can be a useful adjunct to 
tracheal intubation in patients with difficult airway as documented in 
several case reports.13, 14  
A prospective randomized single blind study was designed to 
compare the supraglottic airway devices I-GEL and ILMA as a conduit 
for blind endotracheal intubation in patients undergoing elective surgery 
under general anaesthesia 
After obtaining the Institutional Ethical committee approval, 
eighty adult patients of ASA Physical status 1& 2 of either sex 
undergoing elective surgical procedures under general anaesthesia were 
randomly allocated into two groups, Group A: IGEL(n=40) and Group 
B: ILMA (n=40). Ease of tracheal intubation was assessed by the first 
attempt success rate, the total time required for the intubation. Ease of 
supraglottic device insertion was also assessed by the number of 
attempts and the time required for the device placement. Any 
complication during intubation was noted. 
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The study showed no significant difference between the two 
groups based on the demographic variables. The mean insertion time for 
I-GEL was significantly less than ILMA (p<0.05). There was no 
statistical difference between the two groups in number of attempts 
required for the placement of the supraglottic airway device. 
 The overall success rate, as well as the first attempt success rate 
for blind endotracheal intubation was high in the ILMA and were 95% 
and 87.5% respectively. The failure rate for blind endotracheal 
intubation through the supraglottic device was significantly high in the 
I-GEL (27.5%) with high incidence of esophageal intubation when 
compared to ILMA (p<0.05). The mean time for tracheal intubation was 
equal in both the groups 
 The time required for supraglottic device removal was 
significantly less for I-GEL (p<0.05). There was no statistically 
significant difference in the total time required for successful endo-
tracheal intubation (including the time for airway insertion, tracheal 
intubation, device removal) between both the groups. Complications like 
oesophageal intubation and mucosal trauma were high with the IGEL. 
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CONCLUSION 
 
We conclude that, based on the results of our study, I-GEL aids 
easy and rapid insertion as a supraglottic airway device, but when it is 
used as a conduit for blind endotracheal intubation, the failure rate is 
high as there is more incidence of oesophageal intubation.  In contrary, 
ILMA being a gold standard device meant for intubation guide, has a 
high first attempt success rate for blind endotracheal intubation.  
 
 
 
 
 
 
KEY TO MASTER CHART 
 
 
 
IP NO  : In- patient number 
PS    : American society of Anaesthesiologist 
Physical Status  
Wt Kg  : Weight in kilograms 
MPC   : Mallampatti Classification 
ETT   : Endotracheal tube 
SBP   : Systolic Blood pressure 
DBP   : Diastolic blood pressure 
MAP   : Mean arterial pressure 
Pre- Ind  : Pre-induction 
Post-Ind  : Post-Induction 
         
Sl.NO. NAME SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP PRE-IND
POST-
IND 1 MIN 5 MIN
1 GEETHA 110 80 90 96 70 79 120 76 91 120 80 93 86 80 88 88
2 SARANYA 110 80 90 96 66 76 110 74 86 108 76 87 88 82 88 86
3 SATISH 126 76 93 110 70 83 120 80 93 118 70 86 86 84 88 88
4 SENGALI 116 86 96 102 62 75 110 76 87 108 72 84 87 88 89 89
5 AGIVAN 126 70 89 100 60 73 116 70 85 114 60 78 90 84 89 92
6 RABITA 118 70 86 110 60 77 110 70 83 110 68 82 90 86 88 84
7 EMAROSE 120 80 93 96 66 76 116 76 89 106 70 82 88 84 89 88
8 AVINASH 120 80 93 90 66 74 116 74 88 110 68 82 80 70 78 82
9 GOPI 116 80 92 98 64 75 120 76 91 112 72 85 88 80 88 86
10 MARY 126 80 95 106 70 82 118 76 90 116 70 85 80 76 84 82
11 LAKSHMI 128 80 96 106 70 82 116 78 91 110 72 85 80 76 84 82
12 RAMYA 106 70 82 90 60 70 110 66 81 100 70 80 80 74 83 80
13 RADHIKA 116 80 92 100 70 80 118 76 90 112 70 84 86 80 87 88
14 RADHA 116 70 85 96 70 79 114 76 89 112 70 84 84 80 85 86
15 RAJA 118 74 89 96 66 76 118 76 90 110 70 83 80 76 86 86
16 CHITRA 120 80 93 100 70 80 110 76 87 116 74 88 86 84 88 86
17 UMA SHANKAR 118 70 86 100 70 80 120 76 91 110 74 86 86 78 86 84
18 SHANTHI 122 76 91 98 70 79 116 76 89 108 66 80 86 80 88 84
19 MOHAN 126 80 95 100 76 84 110 82 91 112 70 84 84 78 85 82
20 ARUL RAJ 106 68 81 94 60 71 110 68 82 106 66 79 84 76 82 80
21 SHANKAR 126 80 95 100 70 80 116 80 92 114 80 91 89 84 88 88
22 DHANASEKAR 120 78 92 100 70 80 116 80 92 110 76 87 90 86 88 84
23 PRIYA 110 70 83 96 62 73 110 72 85 106 70 82 86 87 89 88
24 RANI 116 70 85 100 74 83 118 78 91 112 76 88 86 88 90 87
25 SELVI 117 70 86 98 68 78 116 70 85 112 68 83 84 87 86 86
26 RUKUMANI 116 68 84 96 69 78 110 72 85 118 76 90 79 82 85 82
27 ESWARI 110 76 87 96 67 77 110 78 89 106 72 83 72 76 78 75
28 JAYA PRADHA 120 80 93 106 72 83 116 80 92 114 76 89 86 84 89 88
29 ARAVINDH 116 70 85 100 60 73 118 76 90 112 70 84 80 72 79 76
30 SHANTHA 112 70 84 96 68 77 110 76 87 108 72 84 82 80 88 86
31 GANESH 126 76 93 106 70 82 116 76 89 112 70 84 84 86 88 82
32 SARANYA 116 80 92 98 66 77 118 76 90 108 70 83 86 80 86 82
33 SHANTHI 110 76 87 96 68 77 110 72 85 104 80 88 90 82 92 88
34 ASHOK KUMAR 120 74 89 98 68 78 118 70 86 114 76 89 87 88 90 82
35 KALAIVANI 120 76 91 104 76 85 126 80 95 120 88 99 78 80 84 84
36 MARRIAPPAN 105 74 84 95 60 72 110 76 87 106 72 83 87 89 88 84
37 SHANTINI 100 70 80 94 66 75 106 76 86 104 67 79 74 79 82 80
38 RUKUMANI 120 80 93 90 70 77 126 84 98 110 70 83 94 86 90 89
39 BAGYALAKSHMI 118 70 86 100 66 77 120 76 91 110 70 83 84 80 88 84
40 SENTHIL GANESH 108 76 87 97 64 75 110 70 83 107 70 82 74 78 82 79
     1 MIN AFTER 
INTUBATION
   5 MIN AFTER 
INTUBATION     HEART RATE
GROUP B - ILMA
 PREINDUCTION BP          POST     INDUCTION BP
Sl.NO. NAME SBP DBP MAP SBP DBP MAP SBP DBP MAP SBP DBP MAP PRE-
IND
POST-
IND
1 MIN 5 MIN
1 AMMU 120 84 96 106 70 82 120 80 93 124 80 95 80 76 86 84
2 KANAGAJOTHI 116 76 89 98 68 78 110 80 90 100 70 80 86 88 89 94
3 DEVI 118 82 94 100 66 77 116 80 92 110 70 83 80 82 88 88
4 LAKSHMI 118 78 91 98 68 78 116 80 92 114 72 86 87 88 90 88
5 KADHIRAVAN 110 70 83 96 66 76 106 70 82 110 76 87 84 86 88 86
6 JERRINA 120 78 92 110 68 82 124 76 92 118 70 86 87 89 90 88
7 MUMTAJ 116 80 92 108 68 81 128 86 100 120 80 93 84 86 89 82
8 SABINA 120 82 95 100 70 80 120 80 93 122 80 94 82 84 84 88
9 RUKUMANI 120 86 97 108 70 83 120 80 93 118 80 93 80 74 82 80
10 BABU 106 72 83 90 60 70 108 70 83 104 70 81 76 78 80 78
11 SUGANTHI 124 76 92 104 70 81 120 80 93 126 66 86 84 82 86 84
12 MANI 112 70 84 98 68 78 116 74 88 110 70 83 88 86 90 88
13 BALAJI 116 76 89 100 70 80 120 80 93 122 76 91 80 82 84 84
14 VIDYA 118 78 91 96 70 79 110 80 90 112 82 92 89 90 92 88
15 RADHIKA 116 80 92 98 60 73 118 70 86 116 72 87 88 84 88 86
16 LAKSHMI 120 78 92 100 70 80 120 80 93 118 70 86 88 86 89 90
17 RAJASEKAR 114 76 89 110 72 85 117 80 92 120 80 93 88 90 91 90
18 RAJALAKSHMI 124 76 92 100 70 80 120 84 96 116 70 85 84 83 89 90
19 DAMODHARAN 118 78 91 98 60 73 110 70 83 112 72 85 86 84 87 90
20 VIMALA 120 76 91 98 68 78 116 70 85 118 70 86 81 85 88 94
21 SANGEETHA 116 68 84 99 66 77 112 68 83 118 74 89 80 80 87 90
22 MURUGAN 116 68 84 90 60 70 110 70 83 114 68 83 82 86 87 90
23 VISWANATHAN 118 70 86 97 67 77 114 67 83 116 76 89 82 88 89 86
24 CHINNAMMAAL 114 74 87 96 70 79 126 86 99 120 68 85 86 84 85 88
25 PUROSHOTHAMAN 108 68 81 90 60 70 110 70 83 106 70 82 86 84 88 87
26 POONGODI 108 70 83 98 68 78 116 80 92 106 70 82 81 78 85 85
27 AMEENA 114 76 89 98 66 77 106 78 87 124 80 95 82 84 86 82
28 ANNAPOORANI 120 76 91 100 60 73 116 70 85 124 72 89 86 84 88 94
29 CHINNASAMY 121 78 92 110 70 83 120 76 91 116 74 88 76 75 80 84
30 MANI 118 70 86 100 70 80 120 80 93 114 72 86 84 82 88 86
31 SANJEEV 130 89 103 100 66 77 118 76 90 126 78 94 80 84 96 94
32 NALAYINI 120 76 91 98 66 77 110 70 83 118 70 86 86 87 89 84
33 SHANKARI 116 70 85 120 76 91 108 70 83 112 72 85 86 88 90 86
34 MUNIYAMMAL 128 76 93 116 70 85 126 80 95 124 70 88 84 84 88 86
35 PARAMESWARAN 126 90 102 110 70 83 120 80 93 128 96 107 90 89 106 99
36 PUNITHA 128 86 100 100 60 73 118 70 86 120 76 91 84 86 98 92
37 PRASAD 122 86 98 106 70 82 124 86 99 118 76 90 84 86 92 88
38 RAJALAKSHMI 120 76 91 100 70 80 118 68 85 116 68 84 84 86 94 92
39 PALANISAMY 128 86 100 100 76 84 124 84 97 126 74 91 82 78 98 91
40 MEENABAI 124 76 92 96 68 77 108 70 83 118 76 90 86 84 88 82
     1 MIN AFTER 
INTUBATION
   5 MIN AFTER 
INTUBATION     HEART RATE
GROUP A - IGEL
 PREINDUCTION BP          POST     INDUCTION BP
PROFORMA 
 
Name              : 
 
Group assigned :   
                                 
Age / Sex  : 
      
IP No   : 
 
Diagnosis                    : 
 
Surgery                        : 
                                             
ASA Status  :     Associated medical illness : 
 
Weight                        : 
 
Airway                        :     MPC 
 
Last Oral intake  : 
 
Premedication  : 
 
Shifted to theatre   : 
 
Monitors –baseline values: HR     : 
 
           SpO2  : 
 
           BP       :      
 
IV access secured       : 
 
Preoxygenation  :    100% oxygen for 3 min   
 
Induction   :     Propofol         mg.    
 
Relaxant                      :     Inj Atracrurium         mg 
 
 
SUPRAGLOTTIC DEVICE: 
 
Size                                : 
 
Insertion time (seconds) : 
 
Number of attempts       : 
Tracheal Intubation  
 
Endotracheal tube size      : 
 
Time (seconds)                 :                          
 
Intubation Attempts                       
 
One (Without Maneuver) : 
   
One (With Maneuver)      :           
 
Two                                  : 
  
TIME  required for  the removal of supraglottic device : 
 
 
Total time required for tracheal intubation                   : 
 
  (including supraglottic device insertion and removal) 
           
 
COMPLICATIONS            : 
 
Saturation <95                             : 
 
Dental trauma                               : 
 
Esophageal intubation                  : 
 
Laryngospasm                              : 
 
Mucosal trauma                            : 
 
 
Hemodynamic parameters : 
 
1. Pre induction Blood pressure -              1. Pre Induction Heart Rate - 
2. Post induction Blood pressure -   2 .Post induction Heart Rate- 
3. BP 1 min after intubation-    3. HR 1 min after intubation- 
4. BP 5 min after intubation-    4. HR 5 min after intubation- 
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